業績

HOME > 業績
  • 総説・解説 【肝胆膵診療のラストマイル】疾患克服を視野に入れた領域 E型肝炎克服に向けた今後の展望
    佐々木 玲奈、神田 達郎、寺井 崇二
    肝胆膵 91巻2号 Page145-150(2025.08)
  • 症例報告 Myelodysplastic Syndrome With Trisomy 8 and Behçet Disease-Like Intestinal and Upper Gastrointestinal Involvement
    Kawata Y, Tominaga K, Kaneko Y, Takashima S, Tani Y, Kojima Y, Takahashi K, Terai S.
    Clin Case Rep. 2025 Aug 22;13(9):e70575. doi: 10.1002/ccr3.70575. eCollection 2025 Sep.
  • 原著 Simultaneous Evaluation of Shear Wave Elastography and C-Peptide Index for Predicting Need of Insulin Therapy in Type 2 Diabetes: A Pilot Study
    Sugita-Hamada M, Yokoo T, Nakajima N, Takahashi Y, Osaki A, Maruyama M, Takamura M, Waguri N, Isokawa O, Terai S.
    J Pers Med. 2025 Jul 1;15(7):277. doi: 10.3390/jpm15070277.
  • 総説・解説 【肝疾患診療の今】各種肝疾患の病態と治療 アルコール性肝障害 Science & Cultureに立脚したアルコール対策
    寺井 崇二、坂牧 僚
    臨牀と研究 102巻7号 Page702-706(2025.07)
  • 総説・解説 【肝硬変-最新の治療】次世代治療,技術の可能性 肝線維化改善,再生療法 線維化治療剤の開発状況を踏まえて
    阿部 寛幸、寺井 崇二
    臨床消化器内科 40巻9号 Page1181-1189(2025.07)
  • 原著 Post Hoc Analysis of Anxiety and Behavioral Changes in Japanese Patients With Inflammatory Bowel Disease due to the COVID-19 Pandemic: Relationship Between Municipal Population at the Place of Residence and Anxiety
    Wagatsuma K, Nojima M, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Takeuchi K, Tamura S, Kinjo F, Ueno N, Naganuma M, Watanabe K, Moroi R, Nishimata N, Motoya S, Kurahara K, Takahashi S, Maemoto A, Hiraga H, Saruta M, Tominaga K, Hisabe T, Tanaka H, Terai S, Inokuchi T, Takedomi H, Narimatsu K, Endo K, Nakamura M, Hisamatsu T, Nakase H; J‐DESIRE Group.
    JGH Open. 2025 Jul 14;9(7):e70209. doi: 10.1002/jgh3.70209. eCollection 2025 Jul.
  • 総説・解説 【細胞外小胞が解き明かす肝胆膵疾患の病態と治療戦略】総論 “細胞外小胞等の臨床応用に関するガイダンス”と今後の国際標準をふまえた細胞外小胞製剤の開発戦略
    寺井 崇二
    肝胆膵 91巻1号 Page13-17(2025.07)
  • 原著 Restoration of the gut-microbiota-liver axis after hepatitis C virus eradication
    Inoue T, Nakayama J, Mori H, Tanaka M, Nakagawa D, Ohnishi M, Funatsu Y, Moriya K, Kawaratani H, Watanabe H, Suda G, Kondo Y, Ide T, Kakizaki S, Miuma S, Suetsugu A, Kawata K, Watanabe T, Iio E, Momoda R, Suzuki Y, Sakamaki A, Watanabe T, Watanabe T, Nagaoka K, Hiasa Y, Terai S, Yoshiji H, Toyoda A, Kurokawa K, Tanaka Y.
    JHEP Rep. 2025 Jun 24;7(9):101494. doi: 10.1016/j.jhepr.2025.101494. eCollection 2025 Sep.
  • 原著 Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosis
    Kawagishi N, Suda G, Tahata Y, Hikita H, Kodama T, Mochida S, Enomoto N, Mawatari S, Kuroda H, Miki D, Kurosaki M, Hiasa Y, Kawada N, Yamashita T, Yatsuhashi H, Yoshiji H, Kato N, Takami T, Miyaaki H, Matsuura K, Asahina Y, Itoh Y, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Ueno Y, Akuta N, Ohara M, Sakamoto N, Takehara T.
    J Gastroenterol. 2025 Jun 20. doi: 10.1007/s00535-025-02275-3.
  • 原著 Slow-Release Prostacyclin Agonist-Immersed Sheet Implantation Suppresses Liver Fibrosis via Hippo Signaling Pathway Activation
    Fujii W, Tomimaru Y, Kobayashi S, Torigata K, Hasegawa K, Harada A, Sasaki K, Hasegawa S, Yamada D, Akita H, Noda T, Takahashi H, Imamura H, Kodama T, Terai S, Sawa Y, Miyagawa S, Doki Y, Eguchi H.
    Hepatol Res. 2025 Jun 17. doi: 10.1111/hepr.14228.